Petra H.M. Peeters, Kay-Tee Khaw, Guri Skeie, Ingegerd Johansson, NJ Wareham, Ursula Bachlechner, María José Sánchez, José María Huerta, Jasmine Neamat-Allah, Pietro Ferrari, Antonia Trichopoulou, Androniki Naska, Emily Sonested, Veronique Chajes, Elisabete Weiderpass, Marc J. Gunter, Carine Biessy, Anna Winkvist, Eva Ardanaz, Philippos Orfanos, Antonio Agudo, Franҫoise Clavel-Chapelon, Isabelle Romieu, Timothy J. Key, Paolo Vineis, Guy Fagherazzi, Miren Dorronsoro, Augustin Scalbert, Heinz Freisling, Nadia Slimani, Amalia Mattiello, Marianne Uhre Jakobsen, Verana Katzke, José Ramón Quirós, Valeria Pala, Dora Romaguera, Bas Bueno de Mesquita, Giovanna Masala, Heiner Boeing, Marie-Christine Boutron-Ruault, Inge Huybrechts, Camilla Plambeck Hansen, [Chajès,V, Biessy,C, Ferrari,P, Romieu,I, Freisling,H, Huybrechts,I, Scalbert,A, Sliman,N] Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France. [Bueno de Mesquita,B, Romaguera,D, Gunter,MJ, Vineis,P, Peeters,PHM] Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom. [Bueno de Mesquita,B] Department For Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands. Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. [Plambeck Hansen,C, Uhre Jakobsen,M] Department of Public Health, Section of Epidemiology, Aarhus University, Aarhus, Denmark. [Clavel-Chapelon,F, Fagherazz,G, Boutron-Ruaul,M] INSERM, Centre for research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women’s Health team, Villejuif, France. [Clavel- Chapelon,F, Boutron-Ruaul,M] University Paris Sud, UMRS 1018, Villejuif, France. [Clavel-Chapelon,F, Boutron-Ruaul,M] Institute Gustave Roussy, Villejuif, France. [Katzke,V, Neamat-Allah,J] The German Cancer Research Center (DKFZ), Heildelberg, Germany. [Boeing,H, Bachlechner,U] Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany. [Trichopoulou,A, Naska,A, Orfanos,P] Hellenic Health Foundation, Athens, Greece. [Trichopoulou,A, Orfanos,P] Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece. [Pala,V] Epidemiology and Prevention Unit, IRCCS Foundation, National Cancer Institute, Milan, Italy. [Masala,G] Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy. [Mattiello,A] Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy. [Skeie,G, Weiderpass,E] Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Norway. [Romaguera,D] Instituto de Investigacion Sanitaria de Palma (IdISPa) and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain. [Agudo,A] Unit of Nutrition, Environment, and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain. [Huerta,JM] Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain. [Huerta,JM, Ardanaz,E, Sánchez,MJ] CIBER Epidemiology and Public Health CIBERESP, Spain. [Ardanaz,E] Navarre Public Health Institute, Pamplona, Spain. [Sánchez,MJ Andalusian School of Public Health, Granada, Spain. [Dorronsoro,M] Public health Direction and Biodonostia- CIBERESP, Basque Regional Health Department, San Sebastian, Spain. [Quirós,JR] Public Health Directorate, Asturias, Spain. [Johansson,I] Department of odontology, Umeå University, Sweden. [Winkvis,A] Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Sweden. [Sonested,E] Department of Clinical Sciences in Malmö, Nutrition Epidemiology, Lund University, Malmö, Sweden. [Key,T] The Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom. [Khaw,K] Clinical Gerontology Unit, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, United Kingdom. [Wareham,NJ] MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, United Kingdom. [Peeters,PHM] Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands., Funding: The EPIC- PANACEA ((European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of home And obesity) project received funding from the Public Health Programme of the European Union (2005328). EPIC was financially supported by the European Commission: Public Health and Consumer Protection Directorate 1993–2004, and Research Directorate-General 2005. Ligue contre le Cancer, Société 3M, Mutuelle
Background Few epidemiological studies have examined the association between dietary trans fatty acids and weight gain, and the evidence remains inconsistent. The main objective of the study was to investigate the prospective association between biomarker of industrial trans fatty acids and change in weight within the large study European Prospective Investigation into Cancer and Nutrition ( EPIC) cohort. Methods Baseline plasma fatty acid concentrations were determined in a representative EPIC sample from the 23 participating EPIC centers. A total of 1,945 individuals were followed for a median of 4.9 years to monitor weight change. The association between elaidic acid level and percent change of weight was investigated using a multinomial logistic regression model, adjusted by length of follow- up, age, energy, alcohol, smoking status, physical activity, and region. Results In women, doubling elaidic acid was associated with a decreased risk of weight loss ( odds ratio ( OR) = 0.69, 95% confidence interval ( CI) = 0.55- 0.88, p = 0.002) and a trend was observed with an increased risk of weight gain during the 5- year follow- up ( OR = 1.23, 95% CI = 0.97- 1.56, p = 0.082) ( p- trend, The EPIC-PANACEA ((European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of home And obesity) project received funding from the Public Health Programme of the European Union (2005328). EPIC was financially supported by the European Commission: Public Health and Consumer Protection Directorate 1993-2004; Research Directorate-General 2005. Ligue contre le Cancer, Societe 3M, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center, Federal Ministry of Education and Research (Germany); Danish Cancer Society (Denmark); Health Research Institute Carlos III (RTICC Rd06/0020/0091 and Rd12/0036/0018) from the Spanish Ministry of Health, the participating regional governments and institutions (Spain); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, the Wellcome Trust (United Kingdom); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer, National Research Council, Associazione Italiana per la Ricerca sul Cancro-AIRC (Italy); Dutch Ministry of Public Health, Welfare and Sports, Dutch Ministry of Health, Dutch Prevention Funds, LK Research Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) (The Netherlands); Swedish Cancer Society, Swedish Scientific Council, Regional Government of Skane (Sweden); Norwegian Cancer Society (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.